U.S. Markets open in 27 hrs, 56 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 4.6101 09:31 AM EST | |
|---|---|---|
| Day High | 4.74 09:55 AM EST |
|
| Range | 0.13 |
| Volume | 786,174 | |
|---|---|---|
| 30-Day Avg Vol | 2.63 M |
|
| Difference | -70.15% |
| Market Cap | 195.77 M | |
|---|---|---|
| Mkt Cap Chg | -838,424 |
| Shares Out | 41.92 M | |
|---|---|---|
| % Shrs Traded | 1.88% | |
| 1yr EPS Est | -0.59 |
| 52-Wk Low | 1.21 | |
|---|---|---|
| 52-Wk High | 10.00 |
|
| Range | 8.79 |
| Prev Close | 4.69 11/5/09 | |
|---|---|---|
| Today's Open | 4.68 | |
| Change | -0.21% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.84 M |
| Revenue (LFY) | 28.72 M | |
|---|---|---|
| Earnings (LFY) | -15.47 M | |
| Earnings (MRQ) | -9.71 M | |
| Next Earn Est | -0.205 | |
| Next Earnings | 11/13/2009 |
|
| EPS (TTM) | -0.82 | |
| 1yr EPS Growth | 27.16% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -7.00 | |
| PEG Ratio | — | |
| Return on Equity | -35.41 | |
| Beta | 1.36 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Spectrum Pharmaceuticals sees a rainbow of opportunities in its drug development pipeline. The drug firm, which focuses on anti-cancer therapies, won FDA approval in 2008 for its injectable LEVOleucovorin ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.205 11/13/09 | — — |
—
—
|
| Last Quarter | -0.10 6/30/09 | -0.28 6/30/09 |
-0.18
Missed
|
| 2 Quarters Ago | -0.11 3/31/09 | 0.02 3/31/09 |
0.13
Beat
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 8.14 M | 28.72 M |
| Gross Profit | 5.75 M | 27.37 M |
| Operating Income | -9.83 M | -14.47 M |
| Net Income | -9.71 M | -15.47 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts